X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mptp-treated monkeys (247) 247
neurosciences (214) 214
animals (207) 207
parkinson's disease (161) 161
basal ganglia (114) 114
humans (114) 114
index medicus (109) 109
male (108) 108
parkinsons-disease (95) 95
clinical neurology (82) 82
subthalamic nucleus (75) 75
dopamine (66) 66
disease models, animal (62) 62
rats (60) 60
pharmacology & pharmacy (59) 59
female (58) 58
substantia-nigra (50) 50
dopamine - metabolism (49) 49
parkinson disease - physiopathology (45) 45
mptp-treated monkey (44) 44
l-dopa (40) 40
mptp (39) 39
neurons (38) 38
parkinson disease - drug therapy (37) 37
dyskinesia (35) 35
levodopa-induced dyskinesias (35) 35
neurology (33) 33
brain (32) 32
macaca fascicularis (32) 32
analysis (31) 31
striatum (29) 29
deep brain-stimulation (28) 28
globus-pallidus (28) 28
antiparkinson agents - therapeutic use (27) 27
globus pallidus (27) 27
parkinson’s disease (27) 27
rats, sprague-dawley (27) 27
monkeys (26) 26
neurons - physiology (26) 26
high-frequency stimulation (25) 25
levodopa - adverse effects (25) 25
movement disorders (25) 25
corpus striatum - metabolism (23) 23
levodopa (23) 23
motor activity - drug effects (23) 23
antiparkinson agents - adverse effects (22) 22
levodopa - pharmacology (22) 22
neuroprotection (22) 22
nigra pars reticulata (22) 22
parkinson disease - metabolism (22) 22
parkinson disease, secondary - chemically induced (22) 22
parkinsonian disorders - physiopathology (22) 22
psychiatry (22) 22
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (21) 21
article (21) 21
central-nervous-system (21) 21
corpus striatum - drug effects (21) 21
parkinson disease - therapy (21) 21
parkinsons disease (21) 21
dopa-induced dyskinesia (20) 20
macaca mulatta (20) 20
neurons - drug effects (20) 20
parkinson disease - pathology (20) 20
primates (20) 20
deep brain stimulation (19) 19
dose-response relationship, drug (19) 19
monkey (19) 19
neurons - metabolism (19) 19
parkinsonism (19) 19
prefrontal cortex (19) 19
substantia nigra (19) 19
antiparkinson agents - pharmacology (18) 18
behavior, animal - drug effects (18) 18
disease (18) 18
levodopa - therapeutic use (18) 18
tyrosine 3-monooxygenase - metabolism (18) 18
6-hydroxydopamine-lesioned rats (17) 17
mptp-treated mice (17) 17
nervous system (17) 17
neuronal-activity (17) 17
time factors (17) 17
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology (16) 16
biochemistry & molecular biology (16) 16
glutamate (16) 16
dopaminergic-neurons (15) 15
dyskinesia, drug-induced - physiopathology (15) 15
electrophysiology (15) 15
messenger-rna levels (15) 15
neurodegenerative diseases (15) 15
parkinson disease, secondary - physiopathology (15) 15
phenols (15) 15
substantia nigra - drug effects (15) 15
adenosine (14) 14
animal models (14) 14
c-fos expression (14) 14
gene-expression (14) 14
immunohistochemistry (14) 14
mice (14) 14
motor complications (14) 14
parkinsonian disorders - drug therapy (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF NEURAL TRANSMISSION, ISSN 0300-9564, 08/2018, Volume 125, Issue 8, pp. 1273 - 1286
Adenosine is an endogenous purine nucleoside that regulates several physiological functions, at the central and peripheral levels. Besides, adenosine has... 
Basal ganglia | DOPA-INDUCED DYSKINESIA | Serotonin | LEVODOPA-INDUCED DYSKINESIAS | GLOBUS-PALLIDUS | ANTIPARKINSONIAN ACTIVITY | Caudate-putamen | NEUROSCIENCES | RAT MODEL | CLINICAL NEUROLOGY | HEMIPARKINSONIAN RATS | MPTP-TREATED MONKEYS | MESSENGER-RNA | ANIMAL-MODELS | Clinical trial | Primate | Rodent
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0127953
Journal Article
Cerebral Cortex, ISSN 1047-3211, 03/2000, Volume 10, Issue 3, pp. 252 - 262
The orbitofrontal cortex has been ascribed a role in the inhibitory control, as well as in the emotional control, of behaviour. While damage to the... 
OBJECT RETRIEVAL | MPTP-TREATED MONKEYS | DISSOCIATION | RHESUS-MONKEYS | BEHAVIOR | MACACA | ABLATION | FRONTAL-LOBE DAMAGE | DEFICITS | NEUROSCIENCES | LESIONS | Neuropsychological Tests | Mental Processes - physiology | Neural Inhibition - physiology | Animals | Callithrix - physiology | Prefrontal Cortex - physiology | Association Learning - physiology
Journal Article
Psychopharmacology, ISSN 0033-3158, 01/2008, Volume 196, Issue 4, pp. 643 - 648
Selective phosphodiesterase (PDE) inhibitors improve the formation of hippocampus-dependent memories in several rodent models of cognition. However, studies... 
PDE5 | Executive function | PDE4 | Attention | Monkey | Cyclic AMP | Cognition | Biomedicine | Rolipram | Cyclic GMP | Primate | Sildenafil | Pharmacology/Toxicology | Psychiatry | Object retrieval | Phosphodiesterase | monkey | AVOIDANCE-RESPONSE | rolipram | primate | cyclic AMP | PHARMACOLOGY & PHARMACY | LONG-TERM POTENTIATION | MOTOR DEFICITS | cognition | PSYCHIATRY | cyclic GMP | LEARNING IMPAIRMENT | sildenafil | NEUROSCIENCES | PREFRONTAL CORTEX | MPTP-TREATED MONKEYS | attention | PHOSPHODIESTERASE INHIBITION | object retrieval | RECOGNITION MEMORY | phosphodiesterase | RADIAL-ARM MAZE | HUNTINGTONS-DISEASE | executive function | Purines - pharmacology | Macaca fascicularis | Phosphodiesterase Inhibitors - pharmacology | Male | Problem Solving - physiology | Psychomotor Performance - drug effects | Injections, Intramuscular | Mental Recall - drug effects | Cognition - drug effects | Sulfones - pharmacology | Piperazines - pharmacology | Psychomotor Performance - physiology | Sildenafil Citrate | Attention - physiology | Animals | Prefrontal Cortex - drug effects | Mental Recall - physiology | Attention - drug effects | Cognition - physiology | Rolipram - pharmacology | Prefrontal Cortex - physiology | Problem Solving - drug effects | Birds | Inhibitor drugs | Brain research | Neuropsychology | Animal behavior | Animal cognition | Original Investigation
Journal Article